Members directory | Become a member | My DCVMN

Contact us

WeConnectToProtect

March 28, 2025

DCVMN CEO Meets with Chinese Member Companies

CEO Members WeConnectToProtect

October 13, 2024

DCVMN W𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 C𝗮𝗽𝗮𝗰𝗶𝘁𝘆 B𝘂𝗶𝗹𝗱𝗶𝗻𝗴 Workshop in Dubai

WeConnectToProtect Workforce Training Workshop

September 23, 2024

Presenting DCVMN’s strategic focus for 2024-25 at the 2024 UNICEF Vaccine Industry Consultation

CEO DCVMN Advocacy UNICEF WeConnectToProtect

August 1, 2024

DCVMN at the Global Pandemic Preparedness Summit 2024

CEO DCVMN Advocacy WeConnectToProtect

July 2, 2024

DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa”

Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect

June 7, 2024

2023 DCVMN International Annual Report

DCVMN achievements WeConnectToProtect

June 2, 2024

DCVMN CEO Attended a Private Session at the Permanent Mission of France to the UN in Geneva

CEO DCVMN Advocacy Sustainable Regional Manufacturing WeConnectToProtect

May 8, 2024

DCVMN Board at the 8th International Symposium on Immunobiologicals in Rio de Janeiro

Brazil DCVMN Board developingcountries Vaccines & immunization WeConnectToProtect

April 25, 2024

DCVMN CEO Inaugurating the Vaccine World Forum in Pune

CEO developingcountries Vaccines & immunization WeConnectToProtect

April 3, 2024

DCVMN CEO Engagements in Addis Ababa

Africa CEO DCVMN Advocacy developingcountries WeConnectToProtect

March 14, 2024

DCVMN Joint Statement with IFPMA and Trade Associations on Biopharmaceutical Industry Commitments

DCVMN Advocacy developingcountries Statement WeConnectToProtect

December 15, 2023

Panacea Biotec launches EasyFourPol® in India and receives registration of Valganciclovir Powder for Oral Solution in Germany

Global Health Healthcare Milestones Vaccine Equity Vaccines & immunization Vacine Innovation WeConnectToProtect

Our sponsors

Our sponsors

Our sponsors

Our sponsors